PDS Biotechnology Corp
PDSB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001472091
No open-market purchases or sales by PDS Biotechnology Corp insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $6.78M in total; no superinvestor holds it.
Holders of 5% or more of PDSB
Holders whose latest Schedule 13D or 13G filing reports 5% or more of PDS Biotechnology Corp, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Nant Capital, LLC | 13D | 19.90%20.3M shares | New | Sep 21, 20261 filing | Sep 21, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on PDS Biotechnology Corp, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Sep 21, 20269:56 PM ET | Nant Capital, LLCand 1 other | 13D | 19.90%20.3M shares | New | Sep 14, 2026 | SEC |
| Aug 14, 20258:52 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.99%2.28M shares | −5.00 ppfrom 9.99%Below 5% | Jun 30, 2025 | SEC |
| May 15, 20253:27 PM ET | Armistice Capital, LLCand 1 other | 13G | 9.99%4.55M shares | New | Mar 31, 2025 | SEC |
| Aug 27, 2021 | Hirschman Orin | 13G/AOld format | – | – | – | SEC |
| Jun 21, 2021 | Hirschman Orin | 13GOld format | – | New | – | SEC |
| Jun 21, 2021 | Netscientific PLC | 13D/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell PDS Biotechnology Corp shares.
No Form 144 notices for PDS Biotechnology Corp are on file.